Albert David Faces Significant Volatility Amid Broader Market Challenges and Declining Performance
Albert David, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, reaching a new 52-week low. The stock has underperformed its sector and has shown a consistent decline over the past two days. Its performance over the past year has been notably poor, with a substantial decrease in operating profit.
Albert David, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility today, hitting a new 52-week low of Rs. 773.3. The stock has underperformed its sector by 2.96% and has seen a consecutive decline over the past two days, with a total drop of 10.63%. Opening the day with a loss of 4.9%, it reached an intraday low of Rs. 773.3, reflecting a 7.5% decrease.In terms of moving averages, Albert David is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend. The broader market, represented by the Sensex, has also faced challenges, recovering slightly after a significant gap down opening but remaining 3.49% away from its own 52-week low.
Over the past year, Albert David's performance has been notably poor, with a decline of 34.86%, contrasting sharply with the Sensex's drop of only 2.01%. The company's operating profit has decreased at an annual rate of 21.75% over the last five years, and recent quarterly results have shown a substantial decline in net sales and profit after tax. Despite a low debt-to-equity ratio and an attractive valuation based on return on equity, the stock's technical indicators remain bearish.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
